Remember that dietary supplements are designed to complement a healthy lifestylenot replace a balanced diet or appropriate medical care
We highlight ongoing clinical trials for GLP-1 receptor therapies in cancer patients, and offer considerations for preclinical studies, including perspectives on the timing and duration of GLP-1 receptor agonist treatment, concurrent use of standard anticancer therapies, and interpretation of models of cancer risk versus progression
In typical responders, reduced appetite, lower food-cue reactivity, decreased preference for energy-dense foods, and weight loss may reflect coordinated changes in satiety, interoceptive state, and food valuation
We reasoned that replacing the T7 RNAP-transcribed gIII cassette with a chloramphenicol resistance gene would enable the selective enrichment of bacterial cells that express substrates cleaved by a protease of interest when challenged with antibiotic (Fig
BMJ 353, i1585